Ritva Tumelius
Ferring Pharmaceuticals (Switzerland)(CH)
Publications by Year
Research Areas
Proteoglycans and glycosaminoglycans research, Glycosylation and Glycoproteins Research, Immune cells in cancer, Fibroblast Growth Factor Research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → High numbers of macrophages, especially M2‐like (CD163‐positive), correlate with hyaluronan accumulation and poor outcome in breast cancer(2014)234 cited
- → Hyaluronan synthases (HAS1–3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival(2013)129 cited
- → Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer(2012)121 cited
- → Antieosinophilic Activity of Simendans(2007)14 cited
- → High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer(2024)13 cited
- → The co-delivery of Programmed Death 1 ligands enhances and prolongs rAAV-mediated gene expression in pre-immunized mice(2026)